1. Home
  2. DDI vs PRTC Comparison

DDI vs PRTC Comparison

Compare DDI & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleDown Interactive Co. Ltd. American Depository Shares

DDI

DoubleDown Interactive Co. Ltd. American Depository Shares

HOLD

Current Price

$8.95

Market Cap

433.6M

Sector

Technology

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.41

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDI
PRTC
Founded
2008
2015
Country
South Korea
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
433.6M
464.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DDI
PRTC
Price
$8.95
$16.41
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
57.3K
4.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.65
N/A
Revenue Next Year
$2.64
N/A
P/E Ratio
$4.31
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$8.09
$13.30
52 Week High
$11.25
$20.00

Technical Indicators

Market Signals
Indicator
DDI
PRTC
Relative Strength Index (RSI) 48.51 41.11
Support Level $8.64 $15.72
Resistance Level $9.32 $18.10
Average True Range (ATR) 0.35 0.50
MACD -0.04 -0.07
Stochastic Oscillator 40.22 8.09

Price Performance

Historical Comparison
DDI
PRTC

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: